Briacell Therapeutics Corp.
BCTX
Revenue
0.00
0.000.00%
-Assets
641.68k
▲95.43k▲17.47%
12 Months ChangeLiabilities
30.94M
▼-4.67M▼-13.12%
3 Months ChangeFree Cash Flow
-24.58M
▼-24.58M-∞%
-Revenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-11-01
Form 8-K
ID: 0001493152-24-043322
2024-10-02
Form 8-K
ID: 0001493152-24-039218
2024-10-01
Form 8-K
ID: 0001493152-24-039016
2024-09-12
Form 8-K
ID: 0001493152-24-036055
2024-09-11
Form 8-K
ID: 0001493152-24-035737
2024-08-23
Form 8-K
ID: 0001493152-24-033753
2024-07-18
Form 8-K
ID: 0001493152-24-028343
2024-07-05
Form 8-K
ID: 0001493152-24-026349
2024-06-14
Form 10-Q
ID: 0001493152-24-023867
2024-06-14
Form 8-K
ID: 0001493152-24-023860